Genentech, Inc. et al v. Sanofi-Aventis Deutschland GMBH et al

Filing 457

ORDER enlarging briefing schedule (tf, COURT STAFF) (Filed on 9/21/2010)

Download PDF
Genentech, Inc. et al v. Sanofi-Aventis Deutschland GMBH et al Doc. 457 1 Counsel Listed on Following Page 2 3 4 5 6 7 8 9 10 11 12 13 SANOFI-AVENTIS DEUTSCHLAND GMBH, 14 Plaintiff, 15 vs. 16 GENENTECH, INC. and BIOGEN IDEC 17 INC., 18 19 20 21 22 23 24 25 26 27 28 01731.51443/3680378.1 UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA SAN FRANCISCO DIVISION CASE NOS. 08-cv-4909-SI (BZ), 09-cv-4919-SI STIPULATION AND [PROPOSED] ORDER ENLARGING BRIEFING SCHEDULE FOR DEFENDANTS' REPLIES IN SUPPORT OF MOTIONS FOR SUMMARY JUDGMENT [Civil L.R. 6-1, 6-2] Honorable Susan Illston United States District Judge Defendants. Case Nos. 08-cv-4909-SI (BZ); 09-cv-4919-SI STIPULATION AND [PROPOSED] ORDER ENLARGING BRIEFING SCHEDULE FOR DEFENDANTS' REPLIES IN SUPPORT OF MOTIONS FOR SUMMARY JUDGMENT Dockets.Justia.com 1 QUINN EMANUEL URQUHART & 2 SULLIVAN, LLP Charles K. Verhoeven (Bar No. 170151) 3 charlesverhoeven@quinnemanuel.com 50 California Street, 22nd Floor 4 San Francisco, California 94111 Telephone: (415) 875-6600 5 Facsimile: (415) 875-6700 Victoria F. Maroulis (Bar No. 202603) victoriamaroulis@quinnemanuel.com 7 Gabriel S. Gross (Bar No. 254672) gabegross@quinnemanuel.com 8 555 Twin Dolphin Drive, 5th Floor Redwood Shores, California 94065-2139 9 Telephone: (650) 801-5000 Facsimile: (650) 801-5100 10 Attorneys for Defendant Genentech, Inc. 11 TOWNSEND, TOWNSEND & CREW LLP 12 James G. Gilliland (Bar No. 107988) jggilliland@townsend.com 13 David J. Tsai (Bar No. 244479) djtsai@townsend.com 14 James D. Tario (Bar No. 257783) jdtario@townsend.com 15 Two Embarcadero Center, Eighth Floor 16 San Francisco, CA 94111 Telephone: (415) 576-0200 17 Facsimile: (415) 576-0300 18 19 Anne M. Rogaski (Bar No. 184754) amrogaski@townsend.com 379 Lytton Avenue 20 Palo Alto, CA 94301 Telephone: (650) 326-2400 21 Facsimile: (650) 326-2422 22 23 24 25 26 27 28 01731.51443/3680378.1 6 FOLEY HOAG LLP Donald R. Ware (pro hac vice) dware@foleyhoag.com Claire Laporte (pro hac vice) claporte@foleyhoag.com Jeremy A. Younkin jyounkin@foleyhoag.com Seaport World Trade Center West 155 Seaport Boulevard Boston, MA 02210-2600 Telephone: (617) 832-1180 Facsimile: (617) 832-7000 Attorneys for Defendant Biogen Idec Inc. HARVEY SISKIND LLP D. Peter Harvey (Bar No. 55712) pharvey@harveysiskind.com Naomi Jane Gray ngray@harveysiskind.com Raffi V. Zerounian (Bar No. 236388) rzerounian@harveysiskind.com Four Embarcadero Center, 39th Floor San Francisco, California 94111 Telephone: (415) 354-0100 Facsimile: (415) 391-7124 FITZPATRICK, CELLA, HARPER & SCINTO William E. Solander (admitted pro hac vice) wsolander@fchs.com Dominick A. Conde (admitted pro hac vice) dconde@fchs.com Peter D. Shapiro (admitted pro hac vice) pshapiro@fchs.com Joshua A. Davis (admitted pro hac vice) jdavis@fchs.com 1290 Avenue of the Americas New York, New York 10104 Telephone: 212-218-2100 Facsimile: 212-218-2200 Attorneys for Plaintiff Sanofi-Aventis Deutschland GmbH Case Nos. 08-cv-4909-SI (BZ); 09-cv-4919-SI 2 STIPULATION AND [PROPOSED] ORDER ENLARGING BRIEFING SCHEDULE FOR DEFENDANTS' REPLIES IN SUPPORT OF MOTIONS FOR SUMMARY JUDGMENT 1 Pursuant to Civil Local Rules 6-1 and 6-2, Plaintiff Sanofi-Aventis Deutschland GmbH 2 ("Sanofi") and Defendants Genentech, Inc. ("Genentech") and Biogen Idec Inc. ("Biogen") 3 respectfully request that the Court enter the following stipulation regarding the briefing schedule for 4 Defendants' Replies in support of their Motions for Summary Judgment. The parties now AGREE 5 AND STIPULATE to extend the deadline for Defendants to file their Replies from September 23, 6 2010 to September 30, 2010. 7 8 1. Reason for the Request In its Order Granting Sanofi's Motion To Adjourn Hearing for Defendants' Motions for 9 Summary Judgment Under Local Rule 6-3, the Court reset the hearing of Defendants' Motions for 10 Summary Judgment for October 26, 2010. (D.N. 428.) Defendants had initially noticed the hearing 11 for the Motions for September 17, 2010. The Court directed Sanofi to file its Oppositions to the 12 Motions by September 16, 2010 and directed Defendants to file their Replies in Support of the 13 Motions by September 23, 2010. 14 Defendants' Replies are due two days after the close of fact discovery, a critical juncture in 15 this case. Defendants' responses to Sanofi's latest requests for production and interrogatories are 16 due on September 20, and Defendants have noticed depositions of third party fact witnesses for 17 September 20 and 21. Defendants therefore request a one-week extension to provide them adequate 18 time in which to respond to Sanofi's Oppositions to the Motions for Summary Judgment. 19 Defendants do not request any change in the hearing date. The requested extension would leave 25 20 days between the submission of Defendants' replies in support of their motions for summary 21 judgment and the hearing. 22 23 2. Prior Time Modifications The time for Sanofi to answer or otherwise respond to the Complaint was previously 24 extended. The briefing and hearing schedule for Motions to Dismiss for Lack of Jurisdiction 25 brought by Sanofi and its former co-defendants was temporarily vacated. The briefing and hearing 26 schedule for Genentech's Motion To Disqualify McDonnell Boehnen Hulbert and Berghoff LLP was 27 extended by four weeks. The briefing and hearing schedule for Sanofi's Motion for Leave to 28 Amend Its Pleadings and Infringement Contentions was previously extended by five weeks and then 01731.51443/3680378.1 Case Nos. 08-cv-4909-SI (BZ); 09-cv-4919-SI 3 STIPULATION AND [PROPOSED] ORDER ENLARGING BRIEFING SCHEDULE FOR DEFENDANTS' REPLIES IN SUPPORT OF MOTIONS FOR SUMMARY JUDGMENT 1 extended again by seven weeks. The Markman hearing and tutorial were previously continued by 2 45 days. The briefing and hearing schedule for Defendants' Motions for Summary Judgment was 3 previously extended, as described above. 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 01731.51443/3680378.1 3. Effect of Requested Modification The requested modification will have no effect on the rest of the schedule in this action. So Stipulated. Case Nos. 08-cv-4909-SI (BZ); 09-cv-4919-SI 4 STIPULATION AND [PROPOSED] ORDER ENLARGING BRIEFING SCHEDULE FOR DEFENDANTS' REPLIES IN SUPPORT OF MOTIONS FOR SUMMARY JUDGMENT 1 DATED: September 16, 2010 2 3 4 5 6 7 8 DATED: September 16, 2010 9 10 11 12 13 14 15 16 17 18 19 20 21 22 DATED: September__, 2010 23 24 25 26 27 28 01731.51443/3680378.1 HARVEY SISKIND LLP FITZPATRICK, CELLA, HARPER & SCINTO By /s/William E. Solander William E. Solander Attorneys for Plaintiff Sanofi-Aventis Deutschland GmbH QUINN EMANUEL URQUHART & SULLIVAN, LLP By /s/Victoria F. Maroulis Victoria F. Maroulis Attorneys for Defendant Genentech, Inc. DATED: September 16, 2010 TOWNSEND TOWNSEND AND CREW LLP FOLEY HOAG LLP By /s/Claire Laporte Claire Laporte Attorneys for Defendant Biogen Idec Inc. PURSUANT TO STIPULATION, IT IS SO ORDERED. ___________________________________________ Susan Illston United States District Court Judge Case Nos. 08-cv-4909-SI (BZ); 09-cv-4919-SI 5 STIPULATION AND [PROPOSED] ORDER ENLARGING BRIEFING SCHEDULE FOR DEFENDANTS' REPLIES IN SUPPORT OF MOTIONS FOR SUMMARY JUDGMENT 1 2 I, Victoria F. Maroulis, am the ECF User whose identification and password are being used 3 to file this document. Pursuant to General Order 45.X.B, I hereby attest that counsel for Plaintiff 4 has concurred in this filing. 5 6 7 DATED: September 16, 2010 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 01731.51443/3680378.1 QUINN EMANUEL URQUHART & SULLIVAN, LLP By /s/Victoria F. Maroulis Victoria F. Maroulis Attorneys for Defendant Genentech, Inc. Case Nos. 08-cv-4909-SI (BZ); 09-cv-4919-SI 6 STIPULATION AND [PROPOSED] ORDER ENLARGING BRIEFING SCHEDULE FOR DEFENDANTS' REPLIES IN SUPPORT OF MOTIONS FOR SUMMARY JUDGMENT

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?